Dinaciclib enhances NK-cell activity against leukemia cells in preclinical AML models. Enhanced NK-cell activation by dinaciclib-treated AML is associated with downregulation of inhibitory NK ligand HLA-E on leukemia cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712524 | PMC |
| http://dx.doi.org/10.1182/bloodadvances.2019000064 | DOI Listing |
Publication Analysis
Top Keywords
dinaciclib enhances
8
leukemia cells
8
enhances natural
4
natural killer
4
killer cell
4
cell cytotoxicity
4
cytotoxicity acute
4
acute myelogenous
4
myelogenous leukemia
4
leukemia dinaciclib
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!